SCHEMBL24650889

SCHEMBL24650889

CCOC(=O)CC1c2cc(OC)ccc2CC1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.43
OPRM1 P35372 3/20 0.42
MTNR1A P48039 6/20 0.40
MTNR1B P49286 5/20 0.40
NQO2 P16083 4/20 0.40
BRD4 O60885 2/20 0.40
OPRK1 P41145 2/20 0.40
ADRB2 P07550 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
HTR5A P47898 1/20 0.40
SLC6A3 Q01959 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
KDM4E B2RXH2 1/20 0.39
KYAT1 Q16773 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24650883 0.90 NQO2 (0.40) KMT2AMTNR1AMTNR1BNQO2BRD4
SCHEMBL24651110 0.90 KMT2A (0.41) KMT2AOPRM1BRD4KDM4E
SCHEMBL24650924 0.89 MTNR1A (0.44) MTNR1AMTNR1BNQO2KYAT1KYAT3
SCHEMBL24650266 0.88 MTNR1A (0.41) OPRM1MTNR1AMTNR1BNQO2OPRK1
SCHEMBL24650484 0.85 BRD4 (0.41) MTNR1AMTNR1BNQO2BRD4
SCHEMBL24650926 0.85 MIF (0.42) KMT2AOPRM1MTNR1AMTNR1BNQO2
SCHEMBL24650762 0.85 MTNR1A (0.45) MTNR1AMTNR1BNQO2KYAT1KYAT3
SCHEMBL24650925 0.83 NQO2 (0.42) MTNR1AMTNR1BNQO2KDM4E
SCHEMBL24650334 0.81 OPRM1 (0.39) KMT2AOPRM1MTNR1AMTNR1BNQO2
SCHEMBL3315502 0.81 CYP1A2 (0.45) KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022238507-A1 THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS AWAKN LS EUROPE HOLDINGS LIMITED (IE) 2022-11-17 WO disclosed